Cite Filings / LFCR / 0000950170-25-079298

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

LIFECORE BIOMEDICAL, INC. \DE\ Filed 2025-05-29 Acc 0000950170-25-079298

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2026-07-02 SCHEDULE 13D/A Beneficial Ownership Report
2025-05-29 SCHEDULE 13D/A Beneficial Ownership Report
2025-05-28 4 10% owner sold 1,386,060 shares at an average $6.59 ($9,132,503)
2025-05-22 4 Chief Executive Officer gave up 21,532 shares (to pay taxes)
2024-12-26 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…